NCT00641953View on ClinicalTrials.gov

IMX-150 Cream for Diabetic Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Diabetic Peripheral Neuropathy
Interventions
DRUG

IMX-150

(0.3%) 0.5g topically BID to each foot for 4 weeks

DRUG

IMX-150

(0.6%) 0.5g topically BID to each foot for 4 weeks

DRUG

Placebo

0.5 g topically BID to each foot for 4 weeks

Trial Locations (7)

23502

Hampton Roads Center for Clinical Research, Norfolk

32174

Peninsula Research, Ormond Beach

32765

Alpha Medical Research, Oviedo

33156

International Research Associates, LLC, Miami

33458

Health Awareness, Jupiter

33709

Meridien Research, St. Petersburg

34613

Meriden Research, Brooksville

Sponsors
All Listed Sponsors
lead

Procris Pharmaceuticals

INDUSTRY